Moderna says new Covid vaccine was effective against Eris variant in early trial
Moderna's new Covid vaccine generated a robust immune response against the now-dominant Eris variant and another rapidly spreading strain of the virus in an early clinical trial, the biotech company said Thursday. The updated shot is designed to target omicron subvariant XBB.1.5, but the results…
#fornax #pfizer #fl #cdc